Titre:
  • The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab.
Auteur:Campani, Claudia; Galvanin, Clélia; Shim, Ju Hyun; Bouattour, Mohamed; Touchefeu, Yann; Delhoume, Victoria; Rosmorduc, Olivier; Pascale, Alina; An, Jihyun; Lee, Han Chu; Regnault, Hélène; Thabut, Dominique; Paradis, Valérie; Calderaro, Julien; Ziol, Marianne; Beaufrère, Aurélie; Sayadi, Alexandre; Amaddeo, Giuliana; Allaire, Manon; Olivier-Hourmand, Isabelle; Metivier, Chloe; Rondini, Elena; Ronot, Maxime; Ntandja-Wandji, Line; Ozenne, Violaine; Sidali, Sabrina; Marra, Fabio; Hollande, Clémence; Ganne-Carrié, Nathalie; Nahon, Pierre; Lequoy, Marie; Sharma, Rohini; Paris Liver Cancer Group, Massih; Ningarahi, Eric; Trepo, Jean Charles; Nault,
Informations sur la publication:Clinical gastroenterology and hepatology
Statut de publication:Publié, 2025-11-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Artificial Intelligence
Hepatocellular Carcinoma
Immunotherapy
Prognosis
Radiological Response
Langue:Anglais
Identificateurs:urn:issn:1542-3565
info:doi/10.1016/j.cgh.2025.11.018
info:pii/S1542-3565(25)01002-X
info:pmid/41308896